跳至主要内容
临床试验/ACTRN12621000634875
ACTRN12621000634875尚未招募未知

A randomized controlled trial of cognitive bias modification for interpretation (CBM-I) in the management of fear of cancer recurrence/progression in women with breast and ovarian cancer

The University of Sydney0 个研究点目标入组 165 人开始时间: 2021年5月27日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
165

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • To be included patients must:
  • Have a breast or ovarian cancer diagnosis
  • Participants who have high levels of FCR (cut-off score of 13 or higher) or FoP (cut-off score of 34 and higher)
  • 18 years and older
  • Fluent in English
  • Have access to internet and computer competency
  • NOT receiving palliative care

排除标准

  • 未提供

研究者

相似试验